Detalhe da pesquisa
1.
Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections.
N Engl J Med
; 387(1): 21-34, 2022 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35704396
2.
Covid-19 Vaccine Protection among Children and Adolescents in Qatar.
N Engl J Med
; 387(20): 1865-1876, 2022 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36322837
3.
Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.
N Engl J Med
; 385(24): e83, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34614327
4.
Estimating protection afforded by prior infection in preventing reinfection: Applying the test-negative study design.
Am J Epidemiol
; 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38061757
5.
Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting.
Clin Infect Dis
; 73(7): e1830-e1840, 2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33315061
6.
Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar.
Emerg Infect Dis
; 27(5): 1343-1352, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33900174
7.
Protection against Reinfection with the Omicron BA.2.75 Subvariant.
N Engl J Med
; 388(7): 665-667, 2023 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652342
8.
Testing a multicomponent lifestyle intervention for combatting childhood obesity.
BMC Public Health
; 21(1): 824, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33926412
9.
Protection against the Omicron Variant from Previous SARS-CoV-2 Infection.
N Engl J Med
; 386(13): 1288-1290, 2022 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139269
10.
Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2.
N Engl J Med
; 387(18): 1716-1718, 2022 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36223534
11.
Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants.
N Engl J Med
; 387(17): 1620-1622, 2022 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36198139
12.
The impact of COVID-19 on primary health care services in Qatar: 2 years of response and coping 2020-2021.
J Family Med Prim Care
; 11(12): 7743-7749, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36994058
13.
COVID-19 risk score as a public health tool to guide targeted testing: A demonstration study in Qatar.
PLoS One
; 17(7): e0271324, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35853026
14.
Characterizing the effective reproduction number during the COVID-19 pandemic: Insights from Qatar's experience.
J Glob Health
; 12: 05004, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35136602
15.
Assessing the performance of a serological point-of-care test in measuring detectable antibodies against SARS-CoV-2.
PLoS One
; 17(1): e0262897, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35100295
16.
Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses.
BMJ Innov
; 7(2): 327-336, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34192020
17.
SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in Qatar.
Sci Rep
; 11(1): 18182, 2021 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34521903
18.
Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19.
J Glob Health
; 11: 05005, 2021 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33643638
19.
Two prolonged viremic SARS-CoV-2 infections with conserved viral genome for two months.
Infect Genet Evol
; 88: 104684, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33352320
20.
Analytic comparison between three high-throughput commercial SARS-CoV-2 antibody assays reveals minor discrepancies in a high-incidence population.
Sci Rep
; 11(1): 11837, 2021 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34088944